Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-11-15

Clinical Trial Update: Umbilical Cord Blood Mononuclear Cells Therapy in Liver Cirrhosis [Phase 1]

View source ↗

Summary

Clinical trial update for a Phase 1 study evaluating umbilical cord blood mononuclear cells therapy in patients with liver cirrhosis, sponsored by Hebei Medical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Umbilical Cord Blood Mononuclear Cells Therapy

Snippet

Sponsor: Hebei Medical University | Conditions: Liver Cirrhosis | Phase 1 | Status: UNKNOWN